About Us
HD Insights is a semiannual publication that highlights the latest research on Huntington’s disease. We provide our readers with information about the most recent scientific findings and clinical trials that are underway, and we introduce them to the individuals and companies who are working diligently to pursue therapies and even a cure for HD.
HD Insights wouldn’t be possible without the following people:
Publication Staff
Daniel Claassen, M.D. — Editor-in-Chief, Vanderbilt University Medical Center
Margy Rockwood — Deputy Editor
Lise Munsie, Ph.D. — Scientific Content Reviewer
Emma Berkner — Assistant Editor and Web Master
Christina Ullman, MSJ — Art Director
Huntington Study Group
Shari Kinel, J.D. — Chief Executive Officer
Andrew Feigin, M.D. — Chief Medical Officer
Elise Kayson, M.S., ANP — Vice President of Clinical Operations
Christopher A. Ross, M.D., Ph.D. — Chief Scientific Officer
Anne Van Dusen, CHC — Chief Operating Officer
Brett Kinsler, D.C. — Chief Innovation Officer
Michael Lentine, MBA – Chief Financial Officer
Samuel Frank, M.D. — Co-Chair of EMC
Sandra Kostyk, M.D., Ph.D. — Co-Chair of EMC